Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

7. Property and Equipment

7. Property and Equipment

12 Months Ended

Mar. 31, 2015

Property, Plant and Equipment [Abstract]

Property and equipment consists of the following:

	March 31,
	2015			2014
Manufacturing, lab, and other equipment	$	2,937,000		$	3,073,000
Office equipment		278,000			302,000
Furniture and fixtures		82,000			88,000
Leasehold improvements		249,000			269,000
		3,546,000			3,732,000
Less: accumulated depreciation and amortization		(2,751,000	)		(2,761,000	)
	$	795,000		$	971,000

Depreciation and amortization expense amounted to $253,000 and $284,000 for the years ended March 31, 2015 and 2014, respectively.

During the years ended March 31, 2015 and 2014, the Company incurred gains of $13,000 and losses of $39,000, respectively, on the disposal of property and equipment. This amount was recorded within operating expenses in the accompanying consolidated statements of comprehensive (loss) income.

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details